{'fraction_non_alphanumeric': 0.03024193548387097, 'fraction_numerical': 0.004032258064516129, 'mean_word_length': 5.291139240506329, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Cost utility analysis of fixed‐dose and free‐dose combinations of oral medications in type 2 diabetes patients

Fixed‐dose combinations (FXD), medications with more than one active drug ingredient in them, have been a strategy to enhance adherence, but their costs have not been determined, nor have they been compared to the free‐dose combinations (FRC). The objective of this study was to evaluate the cost‐effectiveness of FXD versus the FRC of oral medications among type 2 diabetes patients.